CoChat

Biomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration

Open access

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Human induced pluripotent stem cell derived hepatocytes (hiPSC‐heps) hold promising value for acute liver failure (ALF) treatment, while their therapeutic efficacy is usually limited by low cell bioactivity and untargeted in vivo accumulation. Here, inspired by vascularity supporting cellular architectures in the tissues and organs, a novel vascularized hiPSC‐heps spheroid based on microfluidic microcapsules is presented for liver repair via orthotopic transplantation. The microcapsules are comprised of aqueous cores that facilitate hiPSC‐hep aggregating into spheroids, and hybrid hydrogel shells of sodium alginate and hyaluronic acid methacryloyl (HAMA). By selectively degrading the alginate, the microcapsules are imparted with porous HAMA shells, which not only allowed human umbilical vein endothelial cells (HUVECs) to attach and form vascularized networks, but also facilitated communication between HUVECs and hiPSC‐heps. The specific spatial distributions of these cells in the vascularized hiPSC‐hep spheroids can provide nutrition support, promote the hepatic functions, and avoid immune cell attacks. Based on these features, it is illustrated that the vascularized hiPSC‐hep spheroids can repair the acute failing liver more effectively, indicating their practical values in clinical liver repair.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/advs.202405662

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic illustration of the biomimetic vascularized hiPSC‐hep spheroids. a) Schemes of the microfluidic fabrication and culture process of the biomimetic vascularized microcapsule. b) The obtained microcapsules are assembly implanted into ALF rat for liver regeneration.
Figure 1 Schematic illustration of the biomimetic vascularized hiPSC‐hep spheroids. a) Schemes of the microfluidic fabrication and culture process of the biomimetic vascularized microcapsule. b) The obtained microcapsules are assembly implanted into ALF rat for liver regeneration.CC BY · PubMed Central
Figure 2 Preparation and regulation of the CMC/Ca‐Alg‐HAMA microcapsules. a) Schematics of the microfluidic fabrication process of the microgels, scale bar is 100 µm. b) The microfluidic microcapsules observed using a stereomicroscope. c) SEM images of the whole microcapsule (i), the interior of microcapsules (ii), scale bar is 200 µm, respectively. d,e) Optical microscope images of microcapsules with different Fouter/ Finner, scale bar is 200 µm, respectively. f–i) Overall size and core size distributions of the CMC/Ca‐Alg‐HAMA microcapsules under the different parameters. U referred to as voltage, and d referred to as acquisition distance.
Figure 2 Preparation and regulation of the CMC/Ca‐Alg‐HAMA microcapsules. a) Schematics of the microfluidic fabrication process of the microgels, scale bar is 100 µm. b) The microfluidic microcapsules observed using a stereomicroscope. c) SEM images of the whole microcapsule (i), the interior of microcapsules (ii), scale bar is 200 µm, respectively. d,e) Optical microscope images of microcapsules with different Fouter/ Finner, scale bar is 200 µm, respectively. f–i) Overall size and core size distributions of the CMC/Ca‐Alg‐HAMA microcapsules under the different parameters. U referred to as voltage, and d referred to as acquisition distance.CC BY · PubMed Central
Figure 3 Generation and characterization of porous vascularized microcapsules. a) SEM images of the interior of microcapsules with hiPSC‐hep spheroids encapsulated, scale bars are 50 µm. b) Laser scanning confocal microscopy (LSCM) image of a hiPSC‐hep spheroid‐encapsulated microcapsule with ALB/PCNA staining, scale bar is 50 µm. c) Schemes of the selective degradation and HUVECs coating process of the microcapsules. d) LSCM of the communications between hiPSC‐heps and HUVECs, scale bar is 50 µm. e) SEM images of the interior (i) and surface (ii) of porous vascularized microcapsules with hiPSC‐hep spheroids encapsulated, scale bars are 50 µm in (i) and 10 µm in (ii). f) The viability of hiPSC‐hep spheroids encapsulated in three different hydrogel shells. All data are presented as means ± SE (n = 3). * p < 0.05; *** p < 0.001 (compared with Ca‐Alg). ## p < 0.01; ### p < 0.001 (compared with Ca‐Alg (+), HAMA(+)).
Figure 3 Generation and characterization of porous vascularized microcapsules. a) SEM images of the interior of microcapsules with hiPSC‐hep spheroids encapsulated, scale bars are 50 µm. b) Laser scanning confocal microscopy (LSCM) image of a hiPSC‐hep spheroid‐encapsulated microcapsule with ALB/PCNA staining, scale bar is 50 µm. c) Schemes of the selective degradation and HUVECs coating process of the microcapsules. d) LSCM of the communications between hiPSC‐heps and HUVECs, scale bar is 50 µm. e) SEM images of the interior (i) and surface (ii) of porous vascularized microcapsules with hiPSC‐hep spheroids encapsulated, scale bars are 50 µm in (i) and 10 µm in (ii). f) The viability of hiPSC‐hep spheroids encapsulated in three different hydrogel shells. All data are presented as means ± SE (n = 3). * p < 0.05; *** p < 0.001 (compared with Ca‐Alg). ## p < 0.01; ### p < 0.001 (compared with Ca‐Alg (+), HAMA(+)).CC BY · PubMed Central
Figure 4 The well‐organized vascular network of the vascularized microcapsules. a) Schemes of the vascularized microcapsules with hiPSC‐hep spheroids encapsulated and HUVECs coating. b) LSCM image of single microcapsule with hiPSC‐hep spheroid (green) encapsulated and HUVECs (red), scale bar is 50 µm. c) Close assembly of vascularized microcapsules by HUVECs connections, scale bars are 100 µm. d,e) Single‐row (d) and sheet‐like (e) assembly of the vascularized microcapsules, scale bars are 100 µm.
Figure 4 The well‐organized vascular network of the vascularized microcapsules. a) Schemes of the vascularized microcapsules with hiPSC‐hep spheroids encapsulated and HUVECs coating. b) LSCM image of single microcapsule with hiPSC‐hep spheroid (green) encapsulated and HUVECs (red), scale bar is 50 µm. c) Close assembly of vascularized microcapsules by HUVECs connections, scale bars are 100 µm. d,e) Single‐row (d) and sheet‐like (e) assembly of the vascularized microcapsules, scale bars are 100 µm.CC BY · PubMed Central
Figure 5 In vivo investigations evaluating neovascularization and targeted delivery capabilities. a) Conceptual depiction of ALF rats undergoing treatment with the assembled, vascularized microcapsules. b–d) LSCM visualization of vascular networks, with HUVECs identified by mCheery (red), hiPSC‐heps identified by GFP (green), and nuclei stained with DAPI (blue). Scale bars represent 50 µm on days 1, 3, and 7. e) LSCM representation employed to signify endothelial cells via CD31, with red markers highlighting HUVECs and rat endothelial cells, and green markers pinpointing HUVECs. Scale bar corresponds to 50 µm.
Figure 5 In vivo investigations evaluating neovascularization and targeted delivery capabilities. a) Conceptual depiction of ALF rats undergoing treatment with the assembled, vascularized microcapsules. b–d) LSCM visualization of vascular networks, with HUVECs identified by mCheery (red), hiPSC‐heps identified by GFP (green), and nuclei stained with DAPI (blue). Scale bars represent 50 µm on days 1, 3, and 7. e) LSCM representation employed to signify endothelial cells via CD31, with red markers highlighting HUVECs and rat endothelial cells, and green markers pinpointing HUVECs. Scale bar corresponds to 50 µm.CC BY · PubMed Central
Figure 6 The in vivo therapeutic effect of vascularized microcapsules on ALF rat models. a–c) Evaluation of the ALT, AST, and INR levels of ALF rats from different groups. d) The location and intensity of DIR‐stained hiPSC‐heps in ALF rats detected by small animal imaging system. e) HE and Ki‐67 staining images of different groups, scale bars are 50 µm. All images presented in the results are representative of at least 3 images per liver. f) The positive proportion of Ki‐67 staining in three groups. All data are presented as means ± SE (n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (compared with Normal). # p < 0.05; ## p < 0.01; ### p < 0.001 (compared with ALF). $ p < 0.05; $$ p < 0.01; $$$ p < 0.001 (compared with Spheroids).
Figure 6 The in vivo therapeutic effect of vascularized microcapsules on ALF rat models. a–c) Evaluation of the ALT, AST, and INR levels of ALF rats from different groups. d) The location and intensity of DIR‐stained hiPSC‐heps in ALF rats detected by small animal imaging system. e) HE and Ki‐67 staining images of different groups, scale bars are 50 µm. All images presented in the results are representative of at least 3 images per liver. f) The positive proportion of Ki‐67 staining in three groups. All data are presented as means ± SE (n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001 (compared with Normal). # p < 0.05; ## p < 0.01; ### p < 0.001 (compared with ALF). $ p < 0.05; $$ p < 0.01; $$$ p < 0.001 (compared with Spheroids).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Research works printed but not linked: 1

  1. Xu Y., 2023, Cell Res., 33, 147

Cited by

See all 13

Metadata

Authors
Wang, J., Huang, D., Ren, H., & Zhao, Y.
Affiliations
Nanjing Drum Tower Hospital (CN)
Corresponding author
  • Ren, Haozhen
  • Zhao, Yuanjin
Venue
Advanced Science
Publisher
Wiley
Published
2024-12-24
Volume
12
Issue
6
Pages
e2405662-e2405662
ISSN
2198-3844 (ISSN-L)
OpenAlex
W4405762290
Cited by
13
References
34
Citations by year
2026: 7 · 2025: 6
FWCI
5.44
Type
journal article
Language
en
Open access
Locations
  • Advanced Science (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Shenzhen Fundamental Research Program (JCYJ20190813152616459;JCYJ20210324133214038)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
Keywords
induced pluripotent stem cell-derived hepatocytes, liver regeneration, acute liver failure, sodium alginate, hybrid hydrogels, human umbilical vein endothelial cells, orthotopic transplantation, intercellular communication
MeSH terms
Alginates, Animals, Humans, Liver, Liver Regeneration, Spheroids, Cellular, Hepatocytes, Biomimetics, Mice, Induced Pluripotent Stem Cells, Human Umbilical Vein Endothelial Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration. https://app.cochat.ai/papers/10.1002/advs.202405662
The paper
Wang, J., Huang, D., Ren, H., & Zhao, Y. (2025). Biomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration. Advanced Science. https://doi.org/10.1002/advs.202405662

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.